NEA, an American-based venture capital firm, led a $166m Series C round in Strive Health, a provider of value-based kidney care, with participation from CVS Health Ventures, CapitalG, Echo Ventures, Town Hall Ventures, Ascension Ventures and Redpoint. "Since our founding, we’ve strongly believed that we must meaningfully change the standard of kidney care so people with kidney disease can have better access to care regardless of their socioeconomic background. With the help of our investor partners, this capital raise will propel us further along in our journey to transform kidney care," Chris Riopelle, Strive CEO.